FW: KAP_ Consultant Sponsorship 2026 (Kenya Association of Physicians)
Mohammad Shahjahan (Head of Sales, SPL-Kenya)
Dear Anne,
Facilitate the following as per the allocation to the respective colleagues and account with Square Scientific Office account.
|
Market Name |
Amount |
To be sent |
|
Nairobi 1 |
100,000 |
Daniel Muendo |
|
Nairobi 2 |
45,000 |
|
|
Nairobi 5 |
60,000 |
|
|
Nairobi 4 |
100,000 |
David Machugo |
|
Nairobi 3 |
65,000 |
|
|
Nairobi 6 |
110,000 |
|
|
Nakuru |
80,000 |
Misheck Ndegwa |
|
Nyeri |
120,000 |
David Maingi |
|
Meru |
130,000 |
|
|
Eldoret |
85,000 |
Kevin Wanyama |
|
Kisumu |
80,000 |
|
|
Kisii |
125,000 |
|
|
Mombasa 1 |
80,000 |
Godfred Kimori |
|
Mombasa 2 |
100,000 |
|
|
TOTAL AMOUNT |
1,280,000 |
Colleagues: Please send the MPESA statement to Ms. Sarah after sending the money to the respective doctors as per the attached list.
Sarah: Please do the necessary checking after receiving the statement to confirm the money was sent to the specific persons as per the attached list. We may make calls to the respective numbers to confirm the same.
Thanks,
Shahjahan
From: ad...@acepharm.co.ke <ad...@acepharm.co.ke>
Sent: Thursday, 19 March, 2026 10:53 AM
To: Mohammad Shahjahan (Head of Sales, SPL-Kenya) <shahja...@squaregroup.com>
Subject: RE: KAP_ Consultant Sponsorship 2026 (Kenya Association of Physicians)
Dear Shahjahan,
Please find attached.
Kind Regards,
Sarah
From: Mohammad Shahjahan (Head of Sales, SPL-Kenya) <shahja...@squaregroup.com>
Sent: Thursday, March 19, 2026 10:02 AM
To: ad...@acepharm.co.ke
Subject: FW: KAP_ Consultant Sponsorship 2026 (Kenya Association of Physicians)
Market wise distribution, please.
From: Bulbul Islam (Sr. M-IMD-SPL) <bul...@squaregroup.com>
Sent: Wednesday, 18 March, 2026 5:11 AM
To: Mohammad Shahjahan (Head of Sales, SPL-Kenya) <shahja...@squaregroup.com>
Cc: Rabbir Alam Razu Md.(IMD, SPL) <rab...@squaregroup.com>; Tajbiul Alam Bhuiyan Md. (IMD, SPL) <taj...@squaregroup.com>; Lutfor Rahman Mazumder H.M. (Head of
Marketing, SPL-Kenya) <lutfor...@squaregroup.com>; Jabed Hossain ( CFO, SPL Kenya) <jabe...@squaregroup.com>; Aminul Islam Md. (GM-IMD) <ami...@squaregroup.com>;
'kail...@madawa.co.ke' <kail...@madawa.co.ke>
Subject: RE: KAP_ Consultant Sponsorship 2026 (Kenya Association of Physicians)
Approved.
From: Mohammad Shahjahan (Head of Sales, SPL-Kenya) <shahja...@squaregroup.com>
Sent: Wednesday, March 18, 2026 2:51 AM
To: Bulbul Islam (Sr. M-IMD-SPL) <bul...@squaregroup.com>
Cc: Rabbir Alam Razu Md.(IMD, SPL) <rab...@squaregroup.com>; Tajbiul Alam Bhuiyan Md. (IMD, SPL) <taj...@squaregroup.com>; Lutfor Rahman Mazumder H.M. (Head of
Marketing, SPL-Kenya) <lutfor...@squaregroup.com>; Jabed Hossain ( CFO, SPL Kenya) <jabe...@squaregroup.com>; Aminul Islam Md. (GM-IMD) <ami...@squaregroup.com>;
'kail...@madawa.co.ke' <kail...@madawa.co.ke>
Subject: KAP_ Consultant Sponsorship 2026 (Kenya Association of Physicians)
Dear Sir,
The Kenya Association of Physicians will host its Annual Scientific Conference in Mombasa from 25th to 28th March 2026. KAP is a professional body representing specialists in Kenya, including physicians, cardiologists, diabetologists, and nephrologists, promoting engagement, knowledge sharing, and professional development.
As part of our strategy to strengthen the chronic care portfolio, we have built a solid base of consultant prescribers supporting key brands such as Glympa, Glitamet, Emjard, Bizolol, Linita, and Telmilok. These brands are showing encouraging growth, supported by increasing consultant engagement.
|
Sales Analysis |
2023 |
2024 |
2025 |
Target- 2026 |
Gr. Over 2025 |
|||||
|
S/N |
Product |
Unit |
Value |
Unit |
Value |
Unit |
Value |
Unit |
Value |
|
|
1 |
Angilok 50mg |
42,345 |
5,039,055 |
65,293 |
7,769,867 |
65,852 |
7,405,290 |
70,000 |
8,330,000 |
6% |
|
2 |
Angilok plus 50/12.5mg |
40,117 |
6,178,018 |
55,836 |
8,598,744 |
79,060 |
10,570,746 |
85,000 |
13,090,000 |
8% |
|
3 |
Angilok plus 100/12.5mg |
- |
- |
- |
- |
2,138 |
649,420 |
2,500 |
972,500 |
17% |
|
4 |
Bizolol 5mg |
141 |
48,927 |
10,823 |
3,755,581 |
20,585 |
6,170,326 |
25,000 |
8,675,000 |
21% |
|
5 |
Emjard 10 Tab EPZ |
- |
- |
- |
- |
3,970 |
3,399,937 |
6,000 |
8,925,000 |
51% |
|
6 |
Emjard 25 Tab EPZ |
- |
- |
- |
- |
1,762 |
462,735 |
2,500 |
4,462,500 |
42% |
|
7 |
Emjard M 5/500 Tab EPZ |
- |
- |
- |
- |
1,254 |
520,442 |
1,500 |
2,486,250 |
20% |
|
8 |
Glitamet 50/1000 |
2,299 |
2,478,322 |
5,882 |
6,340,796 |
12,849 |
11,780,729 |
16,000 |
17,248,000 |
25% |
|
9 |
Glitamet 50/500 |
2,041 |
2,200,198 |
3,785 |
4,080,230 |
6,957 |
6,542,934 |
9,000 |
9,702,000 |
29% |
|
10 |
Glympa 10/5 |
1,292 |
2,188,648 |
4,336 |
7,345,184 |
9,496 |
14,961,156 |
12,000 |
20,328,000 |
26% |
|
11 |
Glympa 25/5 |
698 |
1,370,872 |
2,910 |
5,715,240 |
6,879 |
8,765,780 |
8,000 |
15,712,000 |
16% |
|
12 |
Linita 5mg |
115 |
97,405 |
2,898 |
2,454,606 |
6,292 |
603,146 |
7,500 |
6,352,500 |
19% |
|
13 |
Telmilok 40mg |
- |
- |
763 |
352,506 |
2,755 |
1,375,927 |
3,500 |
1,617,000 |
27% |
|
14 |
Telmilok 80mg |
- |
- |
1,105 |
680,680 |
5,177 |
2,309,522 |
5,800 |
3,572,800 |
12% |
|
19,601,445 |
47,093,434 |
71,229,495 |
109,931,250 |
54% |
||||||
Our current sales trend is positive, showing encouraging growth compared to previous years, and we have set ambitious targets for 2026. With a strong Q1 performance and a promising outlook for the remaining quarters, this initiative is expected to further accelerate growth and help us achieve our targets.
Key objectives of the sponsorship & attending of Conference:
- Strengthen relationships with top prescribers driving chronic care sales
- Improve prescription retention and increase share of prescription
- Leverage conference engagement and exhibition presence for brand visibility
- Expected uplift in Q2–Q4 prescriptions and sustained portfolio growth
Following internal evaluation, we have identified 63 high-value consultant doctors across key territories who significantly contribute to prescriptions. We propose partial support (registration and/or transport) to facilitate their participation in the conference.
Total Budget of Sponsorship for KAP:
|
Item |
Consultant to be sponsored |
Amount in KES |
Amount in USD |
|
The Kenya Association of Physicians Conference 2026 |
63 |
1,280,000 |
9,846 |
We seek your approval to proceed with this strategic engagement.
With sincere regards,
Mohammad Shahjahan